Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients

NCT01441752 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

349

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: TCM
DRUG: placebo

Sponsor

xuling